Health News Archive - May 10, 2010
MIAMI, May 10 /PRNewswire/ -- During the 2008 U.S. election, the slogan "drill, baby, drill" was a favorite chant. But now that "spill, baby, spill" is the new mantra, perhaps it's time to find a better way? Or so says award-winning author Dr.
CHICAGO, May 10 /PRNewswire-FirstCall/ -- Advanced Life Sciences Holdings, Inc.
NEWPORT, Ky., May 10 /PRNewswire/ -- Xanodyne Pharmaceuticals, Inc., an integrated specialty pharmaceutical company, today announced that it has tightly focused the strategic direction for the company on the pain management market.
ATLANTA, May 10 /PRNewswire-FirstCall/ -- MedCAREERS GROUP, Inc. (the "Company") (OTC Bulletin Board: MCGI) MedCAREERS Group, Inc. today announced that it has entered into a letter of intent to acquire a nurse staffing company located in the Southeast.
PALM CITY, Fla., May 10 /PRNewswire-FirstCall/ -- Connectyx (Other OTC: CTYX) - Connectyx Technologies Holdings Group, Inc. is pleased to announce that the Company is set to expand its market presence in the U.S. Electronic Health Record (EHR) Market.
SAN DIEGO, May 10 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX) today announced that the Company's Chief Executive Officer, Brian M. Culley, will present at the Rodman & Renshaw Annual Global Investment Conference on Monday, May 17, 2010, at 11:05 a.m.
SAN DIEGO and OTTAWA, May 10 /PRNewswire/ -- Fate Therapeutics, Inc. announces the appointment of Tom Novak, Ph.D., as vice president of research and drug discovery. Dr.
ALISO VIEJO, Calif., May 10 /PRNewswire-FirstCall/ -- Valeant Pharmaceuticals International (NYSE: VRX) today announced that its wholly owned subsidiary, Valeant Canada Limited, has received notice that the New Drug Submission for Onsolis (fentanyl buccal soluble film) has been approved from the Canadian regulatory authority Health Canada.
MARLBOROUGH, Mass., May 10 /PRNewswire/ -- IQuum, Inc. today announced it has been granted an Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for its Liat(TM) Influenza A/2009 H1N1 Assay.
MOUNT OLIVE, N.J., May 10 /PRNewswire/ -- Pinsonault Associates has enhanced their proprietary software application, Today's Accounts. The augmentation creates a new enterprise level, Web-based, managed markets integrated dashboard application called PathfinderRx.